Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
Is Walgreens Boots Alliance stock a Buy, Sell or Hold? Walgreens Boots Alliance stock has received a consensus rating of hold. The average rating score is and is based on 6 buy ratings, 35 hold ratings, and 13 sell ratings.
Based on 12 Wall Street analysts offering 12 month price targets for Walgreens Boots Alliance in the last 3 months. The average price target is $13.67 with a high forecast of $22.00 and a low forecast of $9.00.
Based on short-term price targets offered by 15 analysts, the average price target for Walgreens Boots Alliance comes to $13.00. The forecasts range from a low of $7.00 to a high of $22.00. The average price target represents an increase of 21.16% from the last closing price of $10.73.
(WBA) is an American multinational holding company headquartered in Deerfield, Illinois, which owns the retail pharmacy chains Walgreens in the US and Boots in the UK, as well as several pharmaceutical manufacturing and distribution companies.
A trusted, global innovator in retail pharmacy with more than 12,500 locations across the U.S., Europe and Latin America, WBA plays a critical role in the healthcare ecosystem.
Largest shareholders include Vanguard Group Inc, BlackRock Inc., State Street Corp, Capital World Investors, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, Geode Capital Management, Llc, VFINX - Vanguard 500 Index Fund Investor Shares, Invesco Ltd., Invesco Qqq Trust, Series 1, and VIMSX - Vanguard Mid ...
On June 27, management slashed its adjusted earnings outlook for fiscal 2024 by about 12% to a range between $2.80 and $2.95 per share. Walgreens CEO Tim Wentworth blamed U.S. consumer pressure, which means inflation, and marketplace dynamics, which means pharmacy benefits managers (PBMs), for the losses.
This makes Walgreens Boots Alliance the world's 1721th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
As of 2024-08-24, the Fair Value of Walgreens Boots Alliance Inc (WBA) is -168.31 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 10.3 USD, the upside of Walgreens Boots Alliance Inc is -1734.1%.
As of August 2024 Walgreens Boots Alliance has a market cap of ₹775.70 Billion. This makes Walgreens Boots Alliance the world's 1752th most valuable company by market cap according to our data.
Downgraded To 'BB' On Operating Difficulty; Outlook Negative. Walgreens Boots Alliance Inc. recently reported third-quarter results for the period ended May 31, 2024 and fiscal 2025 guidance notably below our expectations.
Embracing a consumer-centric, technology-enabled business model, WBA is poised to deliver improved health outcomes at lower costs. The segment includes a majority stake in VillageMD, a provider of value-based care, and other assets like Shields Health Solutions and CareCentrix.
Introduction: My name is Margart Wisoky, I am a gorgeous, shiny, successful, beautiful, adventurous, excited, pleasant person who loves writing and wants to share my knowledge and understanding with you.
We notice you're using an ad blocker
Without advertising income, we can't keep making this site awesome for you.